✦ LIBER ✦

Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer

✍ Scribed by Maurie Markman; Alexander Kennedy; Kenneth Webster; Barbara Kulp; Gertrude Peterson; Jerome Belinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Evaluation of 3-Day Topotecan w

✍ Parviz Hanjani; Susan Nolte; Mark S. Shahin 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Evaluation of Pegylated Liposomal Doxoru

✍ Hao Lin; Chih-Wen Tseng; Hung-Yaw Chang; Hsien-Ming Lu; Yu-Che Ou; Chan-Chao Cha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Phase II evaluation of CKD-602, a campto

✍ Hyo-Pyo Lee; Sang-Soo Seo; Sang-Young Ryu; Jong-Hyeok Kim; Yung-Jue Bang; Sang-Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase 2 trial of single agent docetaxel

✍ Maurie Markman; Kristine Zanotti; Kenneth Webster; Gertrude Peterson; Barbara Ku 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

39 Topotecan versus treosulfan in recurr

✍ S. Loibl; W. Meier; A. du Bois; W. Kuhn; J. Pfisterer; R. Kimmig; S. Olbricht; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase 2 Trial of Liposomal Doxorubicin (

✍ Maurie Markman; Alexander Kennedy; Kenneth Webster; Gertrude Peterson; Barbara K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 37 KB